pravastatin has been researched along with Breast Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auboire, L; Landy, S; Le Hello, C; Maïza, D; Perrot, JY | 1 |
| Archer, MC; Duncan, RE; El-Sohemy, A | 1 |
| Gebhardt, A; Niendorf, A | 1 |
| Kuller, LH; Modan, B | 1 |
| Verdery, R | 1 |
| Lupattelli, G; Palumbo, B; Sinzinger, H | 1 |
| Jick, H; Kaye, JA; Meier, CR; Walker, AM | 1 |
| Braunwald, E; Byington, RP; Cobbe, SM; Davis, BR; Friedman, CP; Keech, A; Pfeffer, MA; Sacks, FM; Tonkin, A | 1 |
2 review(s) available for pravastatin and Breast Neoplasms
| Article | Year |
|---|---|
[A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
Topics: Adenocarcinoma, Mucinous; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Estrogens; Female; Galantamine; Humans; Mammography; Mastectomy; Neoplasms, Hormone-Dependent; Nitriles; Paraneoplastic Syndromes; Pravastatin; Progesterone; Radiotherapy, Adjuvant; Raynaud Disease; Seasons; Triazoles; Verapamil | 2010 |
Statins and cancer development.
Topics: Animals; Breast Neoplasms; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Pravastatin | 2005 |
6 other study(ies) available for pravastatin and Breast Neoplasms
| Article | Year |
|---|---|
Effects of pravastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, on two human tumour cell lines.
Topics: Blotting, Southern; Breast Neoplasms; Cell Division; Cholesterol, LDL; Dose-Response Relationship, Drug; Gene Expression; Humans; Hydroxymethylglutaryl CoA Reductases; Immunohistochemistry; Polymerase Chain Reaction; Pravastatin; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Tumor Cells, Cultured | 1995 |
The effect of pravastatin on coronary events after myocardial infarction.
Topics: Breast Neoplasms; Coronary Disease; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Pravastatin | 1997 |
Update in women's health.
Topics: Anticholesteremic Agents; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Disease; Female; Humans; Lovastatin; Pravastatin; Women's Health | 2000 |
Statin induced myopathy does not show up in MIBI scintigraphy.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Breast Neoplasms; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Pain; Pravastatin; Pyridines; Pyrroles; Radionuclide Imaging; Radiopharmaceuticals; Simvastatin; Technetium Tc 99m Sestamibi | 2001 |
Statin use, hyperlipidaemia, and the risk of breast cancer.
Topics: Aged; Anticholesteremic Agents; Breast Neoplasms; Case-Control Studies; Drug Administration Schedule; Female; Humans; Hyperlipidemias; Middle Aged; Pravastatin; Risk Factors | 2002 |
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project.
Topics: Aged; Anticholesteremic Agents; Breast Neoplasms; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Cohort Studies; Comorbidity; Demography; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Muscular Diseases; Pravastatin; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Risk; Risk Assessment; Time | 2002 |